skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

99+ Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

J.P. Morgan Conference Updates

By Mandy Jackson 17 Jan 2020

Updates and coverage of the 2020 J.P. Morgan Healthcare Conference in San Francisco.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

O’Day Lays Out Plan For Gilead’s Continued HIV Dominance

15 Jan 2020

Biktarvy’s powerful sales growth and the potential of a first-in-class capsid inhibitor in both prevention and heavily treatment-experienced patients are key to Gilead’s plan for staying on top in HIV.

HBW Insight : コンシューマーヘルスケア産業のニュース

Bayer Harnessing Skin Microbiome In New Product Development

By Tom Gallen 15 Jan 2020

Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions. 

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Scrip Asia 100 Report Extract

18 Dec 2019

Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Podcast: Significant Approvals, Diabetes and NASH In India, Japan M&A

18 Dec 2019

Join the Asia-based content team for Scrip and the Pink Sheet for their first podcast as they take a look at some of the most significant regional pharma stories of the past few weeks.

Topic drug-approval business-strategies

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Sanofi's €10bn Dupixent Plan: 'We're Going To Put The JAKs Properly In Their Place'

16 Dec 2019

Article

Sanofi's new CEO has ambitious forecasts for Dupixent in atopic dermatitis, asthma and other indications. The French pharma outlined how it plans to reach that goal despite new competition vying to get in.

HBW Insight : コンシューマーヘルスケア産業のニュース

Fragrance Creators Association Readies New Consumer Website To Cap 'Year For The Public'

11 Dec 2019

Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Brexit To And Fro Continues Into Fresh Decade

By Ian Schofield 06 Dec 2019

Three Brexit deadlines have come and gone, and the UK is still a member of the European Union. It will remain so until it agrees a withdrawal deal or leaves without one at the end of January 2020. Alternatively, it could secure yet another extension to the Article 50 period beyond January 31. Or it could decide not to leave at all.

Topic business-strategies policy-and-regulation

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。